James T. Borello RIA
UTHR icon

James T. Borello RIA’s United Therapeutics UTHR Stock Holding History

James T. Borello RIA’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.5K Hold
12
– – ﹤0.01% 716
2026
Q2 		$6.5K Hold
12
– – ﹤0.01% 715
2026
Q1 		$7.12K Hold
12
– – ﹤0.01% 666
2025
Q4 		$5.85K Buy
12
+8
+200% +$3.73K ﹤0.01% 535
2025
Q3 		$1.68K Buy
+4
New +$1.34K ﹤0.01% 753

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

James T. Borello RIA's UTHR Position: Q3 2026 in Review

James T. Borello RIA held its United Therapeutics (UTHR) position steady in Q3 2026 at 12 shares worth $6.5K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

James T. Borello RIA first reported a position in UTHR in Q3 2025 and has held it in 5 quarters since. The position peaked at $7.12K in Q1 2026. 144 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • James T. Borello RIA held 12 shares of United Therapeutics worth $6.5K as of Q3 2026.
  • James T. Borello RIA left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up ﹤0.01% of James T. Borello RIA's portfolio in Q3 2026, its #716 holding.
  • James T. Borello RIA first reported a position in United Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • James T. Borello RIA's United Therapeutics position peaked at $7.12K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.